Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Our products consistently exceed purity levels of 99% or higher.
The wound healing in diabetic patients may be delayed by the downregulation of growth factor receptors and the brisk degradation of growth factors
PubMed laboratory research record [PMID: 40781307] PubMed record related to this compound for laboratory literature review
Product Specifications: 40mg Retatrutide per prefilled pen Triple hormone receptor activation profile Synedica pharmaceutical-grade quality control Designed for precision and repeatability in research settings Each unit is prepared to support accurate dosing protocols and long-duration studies where consistency is critical
US$ 25.76
US$ 27.71
US$ 25.70
